Back to Search
KERI LUNSFORD, M.D., PH.D.
M.D., PH.D.
Transplant Surgery Physician
NPI: 1407021132IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery Physician
Surgery
Code: 208600000X
25MA10654300(NJ)
Transplant Surgery PhysicianPrimary
Transplant Surgery
Code: 204F00000X
25MA10654300(NJ)
Education
OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 2007
Research & Publications (12)
Alloreactive (CD4-Independent) CD8+ T cells jeopardize long-term survival of intrahepatic islet allografts.
PMID 18522544·Am J Transplant·2008
7-preclinical
Recipient immune repertoire and engraftment site influence the immune pathway effecting acute hepatocellular allograft rejection.
PMID 19044209·Cell Transplant·2008
7-preclinical
Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cells.
PMID 18606676·J Immunol·2008
7-preclinical
Thromboembolic therapies in dogs and cats: an evidence-based approach.
PMID 17466757·Vet Clin North Am Small Anim Pract·2007
6-review
Disparate primary and secondary allospecific CD8+ T cell cytolytic effector function in the presence or absence of host CD4+ T cells.
PMID 17579024·J Immunol·2007
4-observational
The Domestic Violence Survivor Assessment (DVSA): a tool for individual counseling with women experiencing intimate partner violence.
PMID 17729174·Issues Ment Health Nurs·2007
8-other
Activation and maturation of alloreactive CD4-independent, CD8 cytolytic T cells.
PMID 16889609·Am J Transplant·2006
7-preclinical
CD4+ T-cell-dependent immune damage of liver parenchymal cells is mediated by alloantibody.
PMID 16123727·Transplantation·2005
4-observational
Targeting LFA-1 and cd154 suppresses the in vivo activation and development of cytolytic (cd4-Independent) CD8+ T cells.
PMID 16339521·J Immunol·2005
7-preclinical
Evidence for tissue-directed immune responses: analysis of CD4- and CD8-dependent alloimmunity.
PMID 15502708·Transplantation·2004
7-preclinical
Critical role for CD8 T cells in allograft acceptance induced by DST and CD40/CD154 costimulatory blockade.
PMID 15196062·Am J Transplant·2004
7-preclinical
Targeting LFA-1 synergizes with CD40/CD40L blockade for suppression of both CD4-dependent and CD8-dependent rejection.
PMID 14510698·Am J Transplant·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 6550 Fannin St, Suite 1661
Houston, TX 77030 - Phone
- (713) 441-6935
Quick Facts
- NPI
- 1407021132
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 19
- Publications
- 12
Are you this provider?
Claim Your Profile